chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8 days after receiving MMR/ Varicella/ pt developed maculopapular rash with fever Tm 100.1
A 'welt' 1.5-2 in in diameter, raised, tender, red, itchy half-way between elbow and shoulder on back of arm. Resolved after 8 days. No VIS given. Did not see vial, syringe was filled.
This is a spontaneous report from a contactable consumer. A 59-year-old female patient received PREVNAR 13, via an unspecified route of administration on the left arm on 03Apr2017 at a single dose for immunization. Medical history included ongoing blood pressure high from 1993 and type II diabetes since 12Jan2007. Her doctor told her that because she had type II diabetes and would be 60 years in Nov2017, she needed to have this injection so that she would not get sick. Concomitant medication included ongoing losartan 100 mg daily (in the morning after breakfast with a glass of water) for blood pressure high ongoing for 5 years. In Apr2017, the patient reported having fever, diarrhea, headaches, and stomach aches. On 04Apr2017 when she woke up in the morning, she started having redness in her left arm, it was red, swollen, itchy and burning. On 05Apr2017, the patient was seen at doctor's office, and she showed the nurse her left arm. The nurse touched her arm and informed the patient that her arm would be okay, "it would go away tonight". The patient reported that it did not go away and each day the redness had increased with more burning and more itching. The patient did not receive treatment for the events. There was no laboratory data. The clinical outcome of the events, fever, diarrhea, headaches, and stomach aches, was unknown. The clinical outcome of the events, redness in her left arm, it was red, swollen, itchy and burning, was not recovered.
chills; growing in redness on upper arm; some itchy feeling at times; feels like there is a hard welt or something underneath the skin; feels like there is a hard welt or something underneath the skin; red circle around the injection site on left arm; its kinda sore; joint pain; muscle pain; fatigued; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (growing in redness on upper arm), PRURITUS (some itchy feeling at times), VACCINATION SITE URTICARIA (feels like there is a hard welt or something underneath the skin), VACCINATION SITE INDURATION (feels like there is a hard welt or something underneath the skin) and VACCINATION SITE ERYTHEMA (red circle around the injection site on left arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included BENAZEPRIL, VITAMIN C;VITAMIN D NOS;VITAMIN E, NORTRIPTYLINE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and SIMVASTATIN for an unknown indication.   On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced ERYTHEMA (growing in redness on upper arm), PRURITUS (some itchy feeling at times), VACCINATION SITE URTICARIA (feels like there is a hard welt or something underneath the skin), VACCINATION SITE INDURATION (feels like there is a hard welt or something underneath the skin), VACCINATION SITE ERYTHEMA (red circle around the injection site on left arm), VACCINATION SITE PAIN (its kinda sore), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and FATIGUE (fatigued). On 06-May-2021, the patient experienced CHILLS (chills). At the time of the report, ERYTHEMA (growing in redness on upper arm), PRURITUS (some itchy feeling at times), VACCINATION SITE URTICARIA (feels like there is a hard welt or something underneath the skin), VACCINATION SITE ERYTHEMA (red circle around the injection site on left arm), VACCINATION SITE PAIN (its kinda sore), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigued) and CHILLS (chills) outcome was unknown.            Treatment includes using ice packs on arm when needed. The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable, reporter didn't provide causality assessment.   This case was linked to MOD-2021-118974 (Patient Link).
pt recvd flu vax 12NOV92 & was adm to hosp on 23NOV92 p/developing SOB, diaphoresis; also c/o tingling, weakness; pt collapsing @ home; dx w/GBS 27NOV92;
Left arm began swelling at injection site and around entire upper arm with mild erythema and warmth to skin.
Developed rash within 24 hrs of vaccine administration. Started on neck, then chest, arms & torso & thighs. Pruritus. Took OTC BENADRYL & cortisone cream.
The pt's grandmother reported that she noticed pt's left upper arm red, swollen and hot to touch at about 10am. Denies any fever or other symptoms. Left upper arm (3" x 2") erythematous, swollen, warm to touch. Advised to use Tylenol and apply warm wet compresses to area.
I have had my booster as well. After taking the 2nd dose I started having high blood pressure and am now pre-diabetic.
RVS. S and S started week of June 15, 2015. Vomiting, unable to stool, fever, eyes swollen, bloody stools.
Excessive, uncontrollable crying over 3 hrs (all night); fever 103, firm, tender swelling on lt thigh @ DTP site;
Lightheadedness, ringing in ears, nausea and dizziness, vertigo. It has persisted on and off for 3 weeks now. I have not gone to my GP yet as I don't know what they can do.
flulike symptoms (chills, body aches,slight fever, headache); Left arm/hand lymphedema (mastectomy area); Joint pain; flare of arthritis in hips, knees, ankles and feet; water retention/puffy face,; swollen lymph nodes in chest; Heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207/59267-1000-1) via an unspecified route of administration in the right arm on 22Mar2021 at 15:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included heart arrhythmia, breast cancer survivor, arthritis, mastectomy, autoimmune disease of blood and thyroid and severe sepsis survivor. The patient was allergic to tramadol (MANUFACTURER UNKNOWN), moxifloxacin (MANUFACTURER UNKNOWN) and hydrocodone (MANUFACTURER UNKNOWN). Concomitant medications included dronedarone hydrochloride (MULTAQ), levothyroxine sodium (SYNTHROID), metoprolol (MANUFACTURER UNKNOWN) and various supplements (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not tested with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021 at 19:00, the patient had flulike symptoms (chills, body aches, slight fever, headache), lymphedema left arm/hand (mastectomy area), followed by joint pain, flare of arthritis (in hips, knees, ankles, feet), water retention/puffy face, swollen lymph nodes in chest and heart palpitations. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were taken for the adverse events included paracetamol (TYLENOL) and ibuprofen (MANUFACTURER UNKNOWN). The clinical outcomes of the events flulike symptoms (chills, body aches, slight fever, headache), lymphedema left arm/hand (mastectomy area), joint pain, flare of arthritis (in hips, knees, ankles, feet), water retention/puffy face, swollen lymph nodes in chest and heart palpitations were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
stroke; feeling funny from that point on & everything went down hill; This is a spontaneous report from a contactable consumer via the Pfizer-sponsored program. A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 26Feb2021 at 11:00 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient felt good all week leading up to the vaccination, until the vaccination was given. From that point on (26Feb2021 at 11:00), the patient started to feel funny and everything went downhill. On 27Feb2021, the patient had a stroke. The clinical outcome of stroke and "feeling funny from that point on & everything went downhill" was unknown.   Information on batch/lot number was requested.
5/2/21 er  hpi: 74 y.o. female who presents to the  Emergency Department by EMS.  EMS was called to the patient's home at an assisted living facility with a complaint of shortness of breath.  When EMS initially arrived the patient was able to talk and tell them that she was feeling poorly and then shortly after this, she started having a lot of trouble breathing and essentially became unresponsive.  EMS started bagging the patient and back to her all the way here.  When she got here she was obviously in respiratory distress.  Once IV access was established, the patient was intubated using RSI. Not much history other than this is available because the patient was unable to speak before she was intubated due to her shortness of breath. transferred to higher level of care   4/30/21 ER HPI: 74 y.o. female who presents with severe lumbar back pain that radiates into her right buttock and right posterior thigh.  She rates it a 7 to 8/10.  The pain has improved since its onset last evening.  She denies any numbness tingling or muscle weakness.  She further denies injury or incontinence.  Patient does have a history of low back pain though none as severe as this. dc'd home
Paxlovid Treatment of COVID-19/Drug Ineffective; Paxlovid Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient received BNT162b2 (BNT162B2), on 29Oct2021 as dose 2 (initial pfizer dose), single (Batch/Lot number: unknown) at the age of 48 years, in right arm for covid-19 immunisation; coviD-19 vaccine janssen (COVID-19 VACCINE JANSSEN), on 16Mar2021 as dose 1, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. Patient received the vaccination. The patient's relevant medical history included: "Anemia" (unspecified if ongoing); "Anxiety disorder" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing), notes: known allergies Pencillin. Patient known allergies included Penicillin. Patient other medical history inlcuded Anemia, anxiety disorderConcomitant medication(s) included: LORAZEPAM. Other medication in 2 weeks included LORAZEPAM.  The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "Paxlovid Treatment of COVID-19/Drug Ineffective"; COVID-19 (medically significant), outcome "unknown", described as "Paxlovid Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19. Patient received Paxlovid from 12May2022 to an unspecified date in May2022 (Lot number-Fy7031) for the treatment of COVID-19. Patient experienced Metallic taste in the mouth and diarrhea on 13May2022 and did not receive any treatment for it.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Several lumps on left side of neck; noticed two weeks after vaccine, have lasted three weeks so far.
Bell's Palsy; This is a spontaneous report from a contactable consumer (caregiver). A male patient (in his 60s) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number, Expiration date and NDC number: Unknown) via an unspecified route of administration in May2021 (about 3 weeks-1 month ago) as UNKNOWN, SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient was completely healthy before the vaccine. On 08Jun2021 (post vaccination), patient's left side of the face was completely dropping and was later diagnosed as Bell's Palsy (this morning). The event led to hospitalization from 08Jun2021 to an unspecified date. The clinical outcome of the event was unknown. Investigation assessment: not provided.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Pt c/o of not feeling well, she was dizzy and thought she was going to vomit.  Code Green called, paramedics assessed the pt.  BP 145/92, HR 66, RR 18.  Pt. Refused to go to the hospital, continued monitoring for 30 minutes,
UrticariaPruritus Mild throat constriction, peri-orbital swelling Narrative:
In  Mid January 2022 I tested positive for COVID-19.  Since then my right ear has been "clogged" and I have  seen an ENT for lack of hearing in my right ear and a ringing sound.  I saw my primary care doctor a few weeks after COVID thinking my ear was clogges with wax.  they referred me to an ENT to remove the wax.  I saw the ENT a few weeks after that and they removed a small amount of wax but he told me likely there was a slight amount of fluid behind my ear drum and to come back and see him in 6 weeks to see if my body absorbed the fluid.  I will see him again in about 3 weeks.
Patient had  a vasovagal syncope episode. Patient received vaccine 12:20pm and began to have symptoms at 12:30pm. Patient began to feel dizzy and lightheaded. Then he began to sweat , skin felt cold  and clammy. As time passed a round 12:40pm he was lethargic and having hard time keeping eyes open. Patient was able to speak  but was not clear. EMS was called at this time. EMS arrived at 12:50pm and by the time EMS arrived patient had  began to become more alerted, was talking clearly and skin was not clammy. EMS took vitals and they were normal.  Patient had stopped sweating. EMS spoke was parent and asked if they would like him to be taken to ER. Parent decided not to have EMS to take child to ER because he was feeling fine and back to normal by this time. EMS explained vasovagal response to patient father and patient and how it can happen with vaccines.  EMS and patient left with father at 1:08pm. Instructed by EMS to follow up with ER if any reoccurring or new symptoms and to make sure patient hydrate and stay hydrated.  I also instructed patient to make doctor aware of adverse reaction and have conversion with doctor in regards to getting second vaccine.
Bright red, sunburn-like rash. It started at neck and then moved down full front of torso the day after the 2nd dose shot. Two days after (today) it has moved to left shoulder and upper arm and low back. The rash isn?t itchy but feels warm to the touch on neck and upper arm. I haven?t done anything to treat it.
Information has been received from a physician concerning a 4 year old white male with no pertinent medical history and drug reactions/allergies who in April 2003, was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (Lot# 644585/1015M). There was no concomitant medication. On approximately 16-APR-2003 the patient developed a rash. One day later, he developed a cold with cough, congestion, and some vomiting. Unspecified medical attention was sought. Subsequently, the patient recovered. No further information was available. Follow-up information indicated that within a week of vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live, the patient developed a fever, cough, congestion, and a rash. He was also noted to have petechiae around his eyes. No lab results were reported. Follow-up was not required, and the patient recovered. The physician considered the events to be related to vaccination with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. No additional information is expected.
Patient received 2nd dose of the COVID-19 vaccine on 2/10/21 and was considered fully vaccinated two weeks later on 2/24/21. On 6/10/21 patient was hospitalized with a possible upper GI bleed. Overnight the patient began to have increased oxygen needs and crackles on auscultation. She was transferred to the ICU, had an abnormal chest x-ray, and tested PCR positive for COVID-19. The patient had acute kidney failure and respiratory failure with a DNR and DNI. She expired on 6/11/21.
Lot FL8095 given on 10/4/2022.  After the fact was determined that lot was determined to expire 8/31/2022.  Stability data received from Pfizer stated product is ok until 4/4/2023.
I got flu like symptoms for 2 days after/It was uncomfortable; This case was reported by a consumer via media and described the occurrence of influenza-like symptoms in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than a month after receiving Shingles vaccine, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.  It was unknown if the reporter considered the influenza-like symptoms to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient himself/herself. The patient reported that got first dose of shingles vaccine a month ago. After vaccination patient experienced flu like symptoms which was recovered in 2 days. Patient stated that It was uncomfortable but getting shingles was much worse patient heard so worth it.
The next day and a day or two later, I had an irregular heartbeat for about 5 mins each time, and then they stopped. It was like skipping a beat.
headache; a numb/tingling sensation on her face; a numb/tingling sensation on her face; nausea; vomiting; fever; diarrhea.; This is a spontaneous report from a contactable consumer (patient). A female of unknown age patient received second dose of dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection), via an unspecified route of administration on 25Jan2021 at single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. Historical vaccination included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) about 4 weeks ago and experienced flu-like symptoms and head ache for about 4 days. After receiving the second dose, in Jan2021, that night/the next morning patient reported headache, a numb/tingling sensation on her face, nausea and vomiting, fever, and diarrhea. She told that the fever seems to have come down, and that the vomiting stopped but the diarrhea had continued. She still had symptoms, and her HCP refuses to see her. The clinical outcome of the event diarrhea was not resolved, event vomiting was resolved on an unspecified date and for all the other events outcome was unknown.  No follow-up attempts are possible. No further information is expected.
Patient diagnosed with shingles at dr's office 6-20-12 started on VALTREX. No previous dx of chickenpox. Did receive two doses of Varicella vaccine, one at 12 mo of age and one at 11 years.
A non-serious spontaneous report of gave H1N1 LAIV to person >49 years old was received from a registered nurse/healthcare professional concerning a 57-year-old female. No relevant medical history was reported for this patient. On 23-Nov-2009 the patient inadvertently received H1N1, Intranasal. There was no adverse event associated with this vaccination error; therefore, treatment and reporter causality assessments were not applicable, and the event was considered resolved.
Developed "zoster" rash to back, size of "silver dollar" with raised, itchy pustules. States called her PMD, was not prescribed medication at this time.
Intense chills,; fever; nausea; headache; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8734) via an unspecified route of administration on 20Mar2021(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021 at 00:00 the patient experienced Intense chills, fever, nausea, headache, fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events Intense chills, fever, nausea, headache, fatigue were recovered with sequelae on an unknown date in Apr2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration on 10Apr2021(at the age of 33-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are possible. No further information is expected.
3 weeks after first dose, developed motor tics including grimacing, neck turning and flexing.
My son came down with the shingles rash and it appears that my son passed a rashless case of shingles to my daughter through a towel. My daughter passed out the same week from severe pain and all of the initial symptoms of shingles. All ER tests revealed she was healthy, no concussion etc.  I believe the original shot has something to do with this since shingles to shingles is not normally passed.  I also believe that a severe case of strep and an antibiotic shot to the butt activated this in patient's nerves back in late January.
Gave covid vaccine at 1312 in the left arm.  Patient returned to work at appointment desk. At approx. 1400 patient went into another room and  that she felt ill. Patient leaned forward in her chair stating she did not feel well and felt like she had a headache and vision was off (eye balls loose in her head).   Took patient's blood pressure and it was 123/66 with a pulse of 67.  While taking patient's blood pressure, she stated that she felt like she was going to faint. Patient felt warm to the touch so we took her temperature and it was 97.7. Patient was given a water bottle and advised to drink. A cold pack was placed on back of patient's neck. After a few minutes patient stated that she was feeling well enough to move into another room. After sitting for a couple of minutes all feeling passed other than being cold and patient returned to work 40 minutes after symptoms onset.
Swollen lips; 6 inch whelps on her torso, hip and butt; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (6 inch whelps on her torso, hip and butt) and LIP SWELLING (Swollen lips) in a 67-year-old female patient who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination.     The patient's past medical history included No adverse event (medical history not reported).   On 25-Jan-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced URTICARIA (6 inch whelps on her torso, hip and butt). On an unknown date, the patient experienced LIP SWELLING (Swollen lips). At the time of the report, URTICARIA (6 inch whelps on her torso, hip and butt) and LIP SWELLING (Swollen lips) outcome was unknown.        The action taken with mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown Route) and mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.